What is the recommended management of knee osteoarthritis?

Management of Knee Osteoarthritis

All patients with symptomatic knee osteoarthritis should be enrolled in an exercise program and counseled regarding weight loss if overweight, with acetaminophen or topical NSAIDs as first-line pharmacologic therapy, escalating to oral NSAIDs if inadequate response. 1

Core Non-Pharmacologic Management (Strongly Recommended)

The foundation of knee OA management requires combining non-pharmacologic and pharmacologic approaches 1, 2. These interventions should be implemented for all patients:

Exercise (Mandatory for All Patients)

• Land-based cardiovascular and/or resistance exercise - strongly recommended 1
• Aquatic exercise - equally effective as land-based; choose based on patient ability and aerobic conditioning 1
• No hierarchy exists between exercise types; supervised programs yield better outcomes 3
• Effect sizes range from 0.57 to 1.0, with benefits lasting 6-18 months 2

Weight Loss (Mandatory for Overweight Patients)

• Strongly recommended for all overweight patients with knee OA 1
• Sustained weight loss improves both pain and function 4
• Large cohort studies demonstrate weight loss reduces knee OA risk 2

Patient Education and Self-Management

• Strongly recommended to improve pain 4
• Includes individualized education packages, group education, and coping skills training 2
• Cost-effective: 80% of education costs offset within one year through reduced healthcare visits 2

Pharmacologic Management Algorithm

First-Line: Acetaminophen or Topical NSAIDs

Acetaminophen (paracetamol) is the oral analgesic to try first 2. If successful, it remains the preferred long-term oral analgesic due to:

• Comparable efficacy to ibuprofen in short-term studies 5
• Safe for long-term use up to 2400-4000 mg/day 5
• No common contraindications, including in elderly patients 5

Topical NSAIDs are conditionally recommended as an alternative first-line option 1:

• Particularly appropriate for patients ≥75 years (preferred over oral NSAIDs) 1
• Clinical efficacy with superior safety profile compared to oral NSAIDs 2
• Effect size of 0.91 in randomized trials 5

Second-Line: Oral NSAIDs

Oral NSAIDs should be used when acetaminophen provides inadequate response 2, 5:

• Strongly recommended when not contraindicated 4
• More efficacious than acetaminophen but with increased gastrointestinal side effects 5
• Effect sizes range from 0.47 to 0.96 2
• For patients with increased GI risk: use non-selective NSAIDs with gastroprotective agents OR selective COX-2 inhibitors 2

Third-Line: Tramadol (Use With Caution)

• Conditionally recommended only when NSAIDs are contraindicated, ineffective, or poorly tolerated 1, 2
• Important caveat: The 2022 AAOS guideline strongly recommends AGAINST oral narcotics including tramadol, citing notable adverse events without effectiveness for pain or function 4
• This represents evolving evidence away from opioid use

Intra-Articular Corticosteroid Injections

• Conditionally recommended for initial management 1
• Specifically indicated for acute flares of knee pain, especially with effusion 2, 5
• Provides short-term benefit (effective at 1 week, not sustained at 24 weeks) 5
• Effect size of 1.27 compared to placebo 2, 5

Adjunctive Therapies (Conditional Recommendations)

Walking Aids and Bracing

• Tibiofemoral braces for tibiofemoral OA: strongly recommended 3
• Medially wedged insoles for lateral compartment OA 1
• Laterally wedged subtalar strapped insoles for medial compartment OA 1
• Walking aids as needed 1

Alternative Modalities (Limited Evidence)

The following are conditionally recommended only for patients with chronic moderate-to-severe pain who are surgical candidates but unwilling/unable to undergo surgery 1:

• Traditional Chinese acupuncture
• Transcutaneous electrical nerve stimulation (TENS)

Treatments NOT Recommended

Strongly Against

• Hyaluronic acid injections: NOT recommended for routine use (moderate strength recommendation against) 4
• Stem cell injections for hip and knee 6
• Arthroscopy for degenerative knee OA 6
• Oral narcotics including tramadol per most recent AAOS guidelines 4

Insufficient Evidence

• Glucosamine, chondroitin, and other SYSADOA: inconsistent recommendations across guidelines 1, 2, 6
• Lateral wedge insoles: consensus against use 7

Surgical Referral Criteria

Joint replacement should be considered for patients with 2:

• Radiographic evidence of knee OA
• Refractory pain and disability despite appropriate conservative management
• End-stage disease (minimal/no joint space) with inability to cope with pain 8

Common Pitfalls to Avoid

1. Skipping non-pharmacologic therapy: Exercise and weight loss are not optional—they are core interventions with strong evidence 1
2. Jumping to opioids: Tramadol and other opioids have fallen out of favor due to adverse events without proven benefit 4
3. Routine use of hyaluronic acid: Despite historical popularity, current evidence does not support routine use 4
4. Premature surgical referral: Ensure adequate trial of conservative management before arthroplasty consideration 8
5. Using oral NSAIDs in elderly without considering topical alternatives: Patients ≥75 should preferentially receive topical NSAIDs 1

Treatment Individualization Factors

Tailor treatment based on 2:

• Knee risk factors: obesity, adverse mechanical factors, physical activity level
• General risk factors: age, comorbidity, polypharmacy
• Pain intensity and disability level
• Presence of inflammation/effusion
• Location and degree of structural damage

The most recent high-quality evidence (2020 ACR/Arthritis Foundation guideline 3 and 2022 AAOS guideline 4) emphasizes a comprehensive multimodal approach with exercise, education, and weight management as the foundation, selective use of NSAIDs (topical preferred in elderly), and avoidance of opioids and routine hyaluronic acid injections.